Skip to main content
Top
Published in: BMC Public Health 1/2014

Open Access 01-12-2014 | Research article

A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka

Authors: Panthihage Ruvini L Dabare, Chandanie A Wanigatunge, BVS Hemantha Beneragama

Published in: BMC Public Health | Issue 1/2014

Login to get access

Abstract

Background

Access to medicines is a universal right. Low availability and low affordability of medicines are issues that deny this right to a significant proportion of the world population. The objective of this study was to determine the availability, price and affordability of essential medicines prescribed to treat non communicable diseases in Sri Lanka.

Methods

Methodology was based on the 2nd edition of the World Health Organization Health Action International Manual. A country survey was conducted and facilities representing both public and private pharmacies were selected. A total of 109 facilities was surveyed. At each facility data on the availability and prices of 50 essential medicines for non communicable diseases were collected. Percentage availability, median price of originator brand and lowest priced generic, median price ratio to the International Reference Price were calculated for surveyed medicines. Affordability was determined using the daily incomes of the lowest - paid unskilled government worker.

Results

Semi government community pharmacies had the highest (>80%) availability while outdoor pharmacies of public health care facilities, private pharmacies and outdoor pharmacies of private hospital showed a fairly high availability (50 - 80%) of surveyed medicines.
Unit price of 76% of selected individual medicines was less than ten Sri Lankan rupees. Out of these 28% of medicines cost less than one Sri Lanka rupee. For 21 of the surveyed medicines the median price ratio to the international reference price was less than one. The prices of originator brands for 14 surveyed medicines were more than five times that of the lowest price generics.
Less than a single day’s wages was adequate to purchase a month's supply of the lowest priced generic of more than 67% of surveyed medicines.

Conclusions

The availability of selected essential medicines was fairly high in both public and private sectors in Sri Lanka. Most medicines are affordable to the lowest income earners in the community. There were many generic brands and generics available for most of the medicines in private and semi government community pharmacies increasing both availability and affordability.
Appendix
Available only for authorised users
Literature
1.
go back to reference United Nations Publication: Indicators for Monitoring the Millennium Development Goals. 2003, United Nations Development Group United Nations Publication: Indicators for Monitoring the Millennium Development Goals. 2003, United Nations Development Group
2.
go back to reference World Health Organization: WHO medicines strategy. 2004, Geneva, Switzerland: Countries at the core 2004-2007 World Health Organization: WHO medicines strategy. 2004, Geneva, Switzerland: Countries at the core 2004-2007
3.
go back to reference Ministry of Health: National list of Essential medicines Sri Lanka: 5th Revision, 2013–2014. 2013, Sri Lanka Ministry of Health: National list of Essential medicines Sri Lanka: 5th Revision, 2013–2014. 2013, Sri Lanka
4.
go back to reference WHO/HAI: Measuring medicine prices, availability, affordability and price components. 2008, Geneva, Switzerland, 2 WHO/HAI: Measuring medicine prices, availability, affordability and price components. 2008, Geneva, Switzerland, 2
5.
go back to reference World Health Organization: Preventing chronic disease: a vital investment. 2005, Geneva, Switzerland World Health Organization: Preventing chronic disease: a vital investment. 2005, Geneva, Switzerland
6.
go back to reference World Health Organization: Prevention of recurrent heart attacks and strokes in low and middle income populations: evidence-based recommendations for policy-makers and health professionals. 2003, Geneva, Switzerland World Health Organization: Prevention of recurrent heart attacks and strokes in low and middle income populations: evidence-based recommendations for policy-makers and health professionals. 2003, Geneva, Switzerland
7.
go back to reference Hogerzeil HV, Jonathan L, Wirtz VJ, P Kishore SP, Selvaraj S, Kiddell-Monroe R, Mwangi-Powell FN FN, von Schoen-Angerer T: Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013, 381: 680-689.CrossRefPubMed Hogerzeil HV, Jonathan L, Wirtz VJ, P Kishore SP, Selvaraj S, Kiddell-Monroe R, Mwangi-Powell FN FN, von Schoen-Angerer T: Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013, 381: 680-689.CrossRefPubMed
8.
go back to reference Mendis S, Fukino K, Cameron A, Laing R, Filipe A, Khatib O, Leowski J, Ewene M: The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Org. 2007, 85 (4): 279-287.CrossRefPubMedPubMedCentral Mendis S, Fukino K, Cameron A, Laing R, Filipe A, Khatib O, Leowski J, Ewene M: The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Org. 2007, 85 (4): 279-287.CrossRefPubMedPubMedCentral
9.
go back to reference Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, Lopez-Jaramillo P, Oguz A, Rahman O, Swidan H, Yusoff K, Zatonski W, Rosengren A, Teo KK: Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011, 378: 1231-1243.CrossRefPubMed Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, Lopez-Jaramillo P, Oguz A, Rahman O, Swidan H, Yusoff K, Zatonski W, Rosengren A, Teo KK: Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011, 378: 1231-1243.CrossRefPubMed
11.
go back to reference Ministry of Healthcare and Nutrition: Sri Lanka – health at a glance. Vol 1. 2008, Sri Lanka Ministry of Healthcare and Nutrition: Sri Lanka – health at a glance. Vol 1. 2008, Sri Lanka
13.
go back to reference Indralal De Silva W: The Age Structure Transition and the Demographic Dividend: An Opportunity for Rapid Economic Take-off in Sri Lanka. Sri Lanka J Adv Soc Stud. 2012, 2 (1): 3-46. Indralal De Silva W: The Age Structure Transition and the Demographic Dividend: An Opportunity for Rapid Economic Take-off in Sri Lanka. Sri Lanka J Adv Soc Stud. 2012, 2 (1): 3-46.
14.
go back to reference Fernando WHKN, Wijesinghe DGNG: Assessment of Nutritional Status and Disease Prevalence among Elderly Population in Elderly Homes in Kandy. Tropical Agric Res. 2010, 21 (3): 229-237. Fernando WHKN, Wijesinghe DGNG: Assessment of Nutritional Status and Disease Prevalence among Elderly Population in Elderly Homes in Kandy. Tropical Agric Res. 2010, 21 (3): 229-237.
16.
go back to reference Ganga Senarathna SMDK: Uthpali Mannapperuma, B 381.M. Rohini Fernandopulle.: Medicine prices, availability and affordability in Sri Lanka. Indian J Pharmacol. 2011, 43 (1): 60-63.CrossRef Ganga Senarathna SMDK: Uthpali Mannapperuma, B 381.M. Rohini Fernandopulle.: Medicine prices, availability and affordability in Sri Lanka. Indian J Pharmacol. 2011, 43 (1): 60-63.CrossRef
17.
go back to reference Balasubramaniam R, Beneragama BVSH, Sri Ranganathan S: A national survey of availability of key essential medicines for children in Sri Lanka. Ceylon Med J. 2011, 56 (3): 101-107. 386CrossRefPubMed Balasubramaniam R, Beneragama BVSH, Sri Ranganathan S: A national survey of availability of key essential medicines for children in Sri Lanka. Ceylon Med J. 2011, 56 (3): 101-107. 386CrossRefPubMed
18.
go back to reference Ministry of Healthcare and Nutrition: National list of Essential medicines Sri Lanka, 4th Revision. 2009, Sri Lanka Ministry of Healthcare and Nutrition: National list of Essential medicines Sri Lanka, 4th Revision. 2009, Sri Lanka
19.
go back to reference Gelders S, Ewen M, Noguchi N, Laing R: Price, availability and affordability: An International comparison of chronic diseases medicines. 2006, World Health Organization and Health Action International: Cairo Gelders S, Ewen M, Noguchi N, Laing R: Price, availability and affordability: An International comparison of chronic diseases medicines. 2006, World Health Organization and Health Action International: Cairo
20.
go back to reference International drug price indicator guide. Edited by: Frye JE. 2012, USA: Management Sciences for Health International drug price indicator guide. Edited by: Frye JE. 2012, USA: Management Sciences for Health
22.
go back to reference van Mourik M, Alexandra C, Marg E, Laing RO: Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010, 10: 25-CrossRefPubMedPubMedCentral van Mourik M, Alexandra C, Marg E, Laing RO: Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010, 10: 25-CrossRefPubMedPubMedCentral
23.
go back to reference WHO: The Selection of essential drugs. Report of the WHO Expert Committee. 2011 (including the 17th model list of Essential Medicines and 3rd WHO model list of Essential Medicines for Children) Technical Report Series No. 965. 2011, Geneva: WHO WHO: The Selection of essential drugs. Report of the WHO Expert Committee. 2011 (including the 17th model list of Essential Medicines and 3rd WHO model list of Essential Medicines for Children) Technical Report Series No. 965. 2011, Geneva: WHO
24.
go back to reference Perera BJC, Cooray JHL (Eds), Sri Lanka Medical Association: Guidelines on the Management of Asthma. 2005, Sri Lanka, 3 Perera BJC, Cooray JHL (Eds), Sri Lanka Medical Association: Guidelines on the Management of Asthma. 2005, Sri Lanka, 3
Metadata
Title
A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka
Authors
Panthihage Ruvini L Dabare
Chandanie A Wanigatunge
BVS Hemantha Beneragama
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-14-817

Other articles of this Issue 1/2014

BMC Public Health 1/2014 Go to the issue